These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 37111673)

  • 21. Inhibiting Bacterial Drug Efflux Pumps via Phyto-Therapeutics to Combat Threatening Antimicrobial Resistance.
    Shriram V; Khare T; Bhagwat R; Shukla R; Kumar V
    Front Microbiol; 2018; 9():2990. PubMed ID: 30619113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Progress in strategies to combat antimicrobial resistance].
    Yin Y; Chen H; Cao L; Tang L; He F
    Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1346-1360. PubMed ID: 30152220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary delivery systems for antimicrobial peptides.
    Caselli L; Rodrigues GR; Franco OL; Malmsten M
    Crit Rev Biotechnol; 2023 Sep; ():1-18. PubMed ID: 37731338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanotechnology as a Promising Approach to Combat Multidrug Resistant Bacteria: A Comprehensive Review and Future Perspectives.
    Hetta HF; Ramadan YN; Al-Harbi AI; A Ahmed E; Battah B; Abd Ellah NH; Zanetti S; Donadu MG
    Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liposome-Based Antibacterial Delivery: An Emergent Approach to Combat Bacterial Infections.
    Ghosh R; De M
    ACS Omega; 2023 Oct; 8(39):35442-35451. PubMed ID: 37810644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic Resistance: Challenges and Strategies in Combating Infections.
    Chavada J; Muneshwar KN; Ghulaxe Y; Wani M; Sarda PP; Huse S
    Cureus; 2023 Sep; 15(9):e46013. PubMed ID: 37900415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-formulation and delivery strategies for the development of bacteriocins as next generation antibiotics.
    Flynn J; Ryan A; Hudson SP
    Eur J Pharm Biopharm; 2021 Aug; 165():149-163. PubMed ID: 34020021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymeric nano- and microparticulate drug delivery systems for treatment of biofilms.
    Birk SE; Boisen A; Nielsen LH
    Adv Drug Deliv Rev; 2021 Jul; 174():30-52. PubMed ID: 33845040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medicinal Chemistry of Inhibitors Targeting Resistant Bacteria.
    Monteiro KLC; Silva ON; Dos Santos Nascimento IJ; Mendonça Júnior FJB; Aquino PGV; da Silva-Júnior EF; de Aquino TM
    Curr Top Med Chem; 2022; 22(24):1983-2028. PubMed ID: 35319372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance?
    Zharkova MS; Orlov DS; Golubeva OY; Chakchir OB; Eliseev IE; Grinchuk TM; Shamova OV
    Front Cell Infect Microbiol; 2019; 9():128. PubMed ID: 31114762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic resistant bacteria: current situation and treatment options to accelerate the development of a new antimicrobial arsenal.
    Tarín-Pelló A; Suay-García B; Pérez-Gracia MT
    Expert Rev Anti Infect Ther; 2022 Aug; 20(8):1095-1108. PubMed ID: 35576494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The alarming antimicrobial resistance in ESKAPEE pathogens: Can essential oils come to the rescue?
    Yu Z; Tang J; Khare T; Kumar V
    Fitoterapia; 2020 Jan; 140():104433. PubMed ID: 31760066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surface modification of nano-drug delivery systems for enhancing antibiotic delivery and activity.
    Osman N; Devnarain N; Omolo CA; Fasiku V; Jaglal Y; Govender T
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jan; 14(1):e1758. PubMed ID: 34643067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic strategies to combat antibiotic resistance.
    Brooks BD; Brooks AE
    Adv Drug Deliv Rev; 2014 Nov; 78():14-27. PubMed ID: 25450262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial Resistance.
    Marston HD; Dixon DM; Knisely JM; Palmore TN; Fauci AS
    JAMA; 2016 Sep; 316(11):1193-1204. PubMed ID: 27654605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial hydrogels: a new weapon in the arsenal against multidrug-resistant infections.
    Ng VW; Chan JM; Sardon H; Ono RJ; García JM; Yang YY; Hedrick JL
    Adv Drug Deliv Rev; 2014 Nov; 78():46-62. PubMed ID: 25450263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promising advances in nanobiotic-based formulations for drug specific targeting against multidrug-resistant microbes and biofilm-associated infections.
    Elfadil D; Elkhatib WF; El-Sayyad GS
    Microb Pathog; 2022 Sep; 170():105721. PubMed ID: 35970290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liposomes as Antibiotic Delivery Systems: A Promising Nanotechnological Strategy against Antimicrobial Resistance.
    Ferreira M; Ogren M; Dias JNR; Silva M; Gil S; Tavares L; Aires-da-Silva F; Gaspar MM; Aguiar SI
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33918529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging Antibacterial Strategies with Application of Targeting Drug Delivery System and Combined Treatment.
    Zhang W; Hu E; Wang Y; Miao S; Liu Y; Hu Y; Liu J; Xu B; Chen D; Shen Y
    Int J Nanomedicine; 2021; 16():6141-6156. PubMed ID: 34511911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review.
    Muteeb G; Rehman MT; Shahwan M; Aatif M
    Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.